Literature DB >> 21181480

Human mesenchymal stem cell co-culture modulates the immunological properties of human intervertebral disc tissue fragments in vitro.

Alessandro Bertolo1, Thomas Thiede, Niklaus Aebli, Martin Baur, Stephen J Ferguson, Jivko V Stoyanov.   

Abstract

The capacity of mesenchymal stem cells (MSCs) to differentiate into intervertebral disc (IVD)-like cells has been well described, but their ability to modulate the inflammatory processes in the IVD remains unclear. We found that tissue obtained by discectomy of degenerated and post-traumatic IVD contains significant amounts of IgG antibodies, a sign of lymphocyte infiltration. Further we investigated whether MSCs in vitro, which were characterized for their multilineage differentiation potential and may have immunomodulatory effects on IVD fragments. IVD fragments were co-cultured in contact with peripheral blood lymphocytes (PBLs) and MSCs, and as functional controls we used contact co-cultures of PBLs stimulated with pokeweed mitogen (2.5 μg/mL) and MSCs. The time course of lymphocyte proliferation (Alamar Blue), IgG (ELISA) and gene expression (RT-PCR) of anti-inflammatory cytokines (TGF-β1, IL-10) by MSCs and pro-inflammatory molecules (IL-1α, IL-1β and TNF-α) by the IVD fragments were analyzed. Depending on the response to the presence of MSCs, the IVD fragments (n = 13) were divided in two groups: responders (n = 9), where inflammation was inhibited by MSCs and non-responders (n = 4), where MSCs did not decrease inflammation. At 1 week in co-culture, MSCs reduced significantly the IgG production in the IVD responders group to 69% and PBLs proliferation to 57% of the control. MSCs expression of the anti-inflammatory TGF-β1 increased with time, while IL-10 was expressed only at day 1. IVD gene expression of TNF-α decreased constantly, whereas IL-1α and IL-1β expression increased. In conclusion, these data suggest that MSCs may modulate disc-specific inflammatory and pain status and aid regeneration of the host tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181480      PMCID: PMC3065597          DOI: 10.1007/s00586-010-1662-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  28 in total

1.  Immunohistochemical detection of Schwann cells in innervated and vascularized human intervertebral discs.

Authors:  W E Johnson; H Evans; J Menage; S M Eisenstein; A El Haj; S Roberts
Journal:  Spine (Phila Pa 1976)       Date:  2001-12-01       Impact factor: 3.468

2.  Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.

Authors:  K Le Blanc; L Tammik; B Sundberg; S E Haynesworth; O Ringdén
Journal:  Scand J Immunol       Date:  2003-01       Impact factor: 3.487

Review 3.  One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.

Authors:  Darwin J Prockop; Carl A Gregory; Jeffery L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

4.  [Inhibitory effects of human bone marrow mesenchymal stem cells and cord blood mononuclear cells on mixed lymphocyte response and PHA induction transformation].

Authors:  Xiao-Fei Wei; Kai-Yan Liu
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2004-06

5.  The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105).

Authors:  F P Barry; R E Boynton; S Haynesworth; J M Murphy; J Zaia
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

6.  Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells.

Authors:  Helen E Gruber; Ray Deepe; Gretchen L Hoelscher; Jane A Ingram; H James Norton; Brian Scannell; Bryan J Loeffler; Natalia Zinchenko; Edward N Hanley; Hazel Tapp
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

7.  Radiographic features of lumbar disc degeneration and self-reported back pain.

Authors:  Stephen R Pye; David M Reid; Rita Smith; Judith E Adams; Kate Nelson; Alan J Silman; Terence W O'Neill
Journal:  J Rheumatol       Date:  2004-04       Impact factor: 4.666

8.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 9.  Aging and degeneration of the human intervertebral disc.

Authors:  J A Buckwalter
Journal:  Spine (Phila Pa 1976)       Date:  1995-06-01       Impact factor: 3.468

10.  Intervertebral disc degeneration: the role of the mitochondrial pathway in annulus fibrosus cell apoptosis induced by overload.

Authors:  François Rannou; Tzong-Shyuan Lee; Rui-Hai Zhou; Jennie Chin; Jeffrey C Lotz; Marie-Anne Mayoux-Benhamou; Jacques Patrick Barbet; Alain Chevrot; John Y-J Shyy
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more
  14 in total

Review 1.  The Michel Benoist and Robert Mulholland yearly European Spine Journal review: a survey of the "medical" articles in the European Spine Journal, 2011.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2011-12-22       Impact factor: 3.134

Review 2.  The future of disc surgery and regeneration.

Authors:  Zorica Buser; Andrew S Chung; Aidin Abedi; Jeffrey C Wang
Journal:  Int Orthop       Date:  2018-11-30       Impact factor: 3.075

3.  * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments.

Authors:  Niloofar Farhang; Jonathan M Brunger; Joshua D Stover; Pratiksha I Thakore; Brandon Lawrence; Farshid Guilak; Charles A Gersbach; Lori A Setton; Robby D Bowles
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

4.  Ex vivo observation of human intervertebral disc tissue and cells isolated from degenerated intervertebral discs.

Authors:  Gabriela Ciapetti; Donatella Granchi; Valentina Devescovi; Elisa Leonardi; Tiziana Greggi; Mario Di Silvestre; Nicola Baldini
Journal:  Eur Spine J       Date:  2012-03-07       Impact factor: 3.134

Review 5.  Intervertebral disc tissue engineering: A brief review.

Authors:  Janja Stergar; Lidija Gradisnik; Tomaz Velnar; Uros Maver
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

Review 6.  Inflammation in intervertebral disc degeneration and regeneration.

Authors:  Maria Molinos; Catarina R Almeida; Joana Caldeira; Carla Cunha; Raquel M Gonçalves; Mário A Barbosa
Journal:  J R Soc Interface       Date:  2015-03-06       Impact factor: 4.118

7.  Improvement of Liver Transplantation Outcome by Heme Oxygenase-1-Transduced Bone Marrow Mesenchymal Stem Cells in Rats.

Authors:  Bin Wu; Hong-Li Song; Yang Yang; Ming-Li Yin; Bo-Ya Zhang; Yi Cao; Chong Dong; Zhong-Yang Shen
Journal:  Stem Cells Int       Date:  2016-01-05       Impact factor: 5.443

Review 8.  Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays.

Authors:  Sephra N Rampersad
Journal:  Sensors (Basel)       Date:  2012-09-10       Impact factor: 3.576

9.  Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.

Authors:  Junran Xie; Dongju Xiao; Yun Xu; Jinning Zhao; Li Jiang; Xuming Hu; Yaping Zhang; Lina Yu
Journal:  Oncotarget       Date:  2016-02-09

10.  Effects of cell type and configuration on anabolic and catabolic activity in 3D co-culture of mesenchymal stem cells and nucleus pulposus cells.

Authors:  Ann Ouyang; Alec E Cerchiari; Xinyan Tang; Ellen Liebenberg; Tamara Alliston; Zev J Gartner; Jeffrey C Lotz
Journal:  J Orthop Res       Date:  2016-10-20       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.